Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells

Ying Fu, Juan Cai, Fanghua Li, Zhiwen Liu, Shaoqun Shu, Ying Wang, Yuxue Liu, Chengyuan Tang, Zheng Dong

Research output: Contribution to journalArticle

Abstract

Cisplatin is a commonly used chemotherapeutic drug for cancer treatment, but its nephrotoxicity may lead to the deterioration of renal function. Previous work has been focused on cisplatin-induced acute kidney disease, whereas the mechanism of chronic kidney disease after cisplatin chemotherapy is largely unknown. In the present study, we have characterized the mouse model of chronic kidney defects induced by repeated low-dose cisplatin treatment. We have also established a relevant cell culture model. In the animal model, C57 mice were given weekly injection of 8 mg/kg cisplatin for 4 wk. This led to a sustained decline of kidney function. These mice showed loss of kidney mass, interstitial fibrosis, continued activation of inflammatory cytokines, and appearance of atubular glomeruli. In the cell model, the BUMPT mouse proximal tubular cell line was treated four times with 1-2 μM cisplatin, resulting in low levels of apoptosis and the expression of fibrosis proteins and profibrotic factors. These data suggest that repeated treatment with low-dose cisplatin causes long-term renal pathologies with characteristics of chronic kidney disease.

Original languageEnglish (US)
Pages (from-to)F1582-F1592
JournalAmerican journal of physiology. Renal physiology
Volume317
Issue number6
DOIs
StatePublished - Dec 1 2019

Fingerprint

Cisplatin
Kidney
Chronic Renal Insufficiency
Therapeutics
Fibrosis
Kidney Diseases
Acute Disease
Animal Models
Cell Culture Techniques
Apoptosis
Pathology
Cytokines
Drug Therapy
Cell Line
Injections
Pharmaceutical Preparations
Neoplasms
Proteins

Keywords

  • chronic kidney disease
  • cisplatin
  • fibrosis
  • kidney repair
  • nephrotoxicity

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells. / Fu, Ying; Cai, Juan; Li, Fanghua; Liu, Zhiwen; Shu, Shaoqun; Wang, Ying; Liu, Yuxue; Tang, Chengyuan; Dong, Zheng.

In: American journal of physiology. Renal physiology, Vol. 317, No. 6, 01.12.2019, p. F1582-F1592.

Research output: Contribution to journalArticle

Fu, Ying ; Cai, Juan ; Li, Fanghua ; Liu, Zhiwen ; Shu, Shaoqun ; Wang, Ying ; Liu, Yuxue ; Tang, Chengyuan ; Dong, Zheng. / Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells. In: American journal of physiology. Renal physiology. 2019 ; Vol. 317, No. 6. pp. F1582-F1592.
@article{c301b45a56464599b957ad3e9f0eca07,
title = "Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells",
abstract = "Cisplatin is a commonly used chemotherapeutic drug for cancer treatment, but its nephrotoxicity may lead to the deterioration of renal function. Previous work has been focused on cisplatin-induced acute kidney disease, whereas the mechanism of chronic kidney disease after cisplatin chemotherapy is largely unknown. In the present study, we have characterized the mouse model of chronic kidney defects induced by repeated low-dose cisplatin treatment. We have also established a relevant cell culture model. In the animal model, C57 mice were given weekly injection of 8 mg/kg cisplatin for 4 wk. This led to a sustained decline of kidney function. These mice showed loss of kidney mass, interstitial fibrosis, continued activation of inflammatory cytokines, and appearance of atubular glomeruli. In the cell model, the BUMPT mouse proximal tubular cell line was treated four times with 1-2 μM cisplatin, resulting in low levels of apoptosis and the expression of fibrosis proteins and profibrotic factors. These data suggest that repeated treatment with low-dose cisplatin causes long-term renal pathologies with characteristics of chronic kidney disease.",
keywords = "chronic kidney disease, cisplatin, fibrosis, kidney repair, nephrotoxicity",
author = "Ying Fu and Juan Cai and Fanghua Li and Zhiwen Liu and Shaoqun Shu and Ying Wang and Yuxue Liu and Chengyuan Tang and Zheng Dong",
year = "2019",
month = "12",
day = "1",
doi = "10.1152/ajprenal.00385.2019",
language = "English (US)",
volume = "317",
pages = "F1582--F1592",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells

AU - Fu, Ying

AU - Cai, Juan

AU - Li, Fanghua

AU - Liu, Zhiwen

AU - Shu, Shaoqun

AU - Wang, Ying

AU - Liu, Yuxue

AU - Tang, Chengyuan

AU - Dong, Zheng

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Cisplatin is a commonly used chemotherapeutic drug for cancer treatment, but its nephrotoxicity may lead to the deterioration of renal function. Previous work has been focused on cisplatin-induced acute kidney disease, whereas the mechanism of chronic kidney disease after cisplatin chemotherapy is largely unknown. In the present study, we have characterized the mouse model of chronic kidney defects induced by repeated low-dose cisplatin treatment. We have also established a relevant cell culture model. In the animal model, C57 mice were given weekly injection of 8 mg/kg cisplatin for 4 wk. This led to a sustained decline of kidney function. These mice showed loss of kidney mass, interstitial fibrosis, continued activation of inflammatory cytokines, and appearance of atubular glomeruli. In the cell model, the BUMPT mouse proximal tubular cell line was treated four times with 1-2 μM cisplatin, resulting in low levels of apoptosis and the expression of fibrosis proteins and profibrotic factors. These data suggest that repeated treatment with low-dose cisplatin causes long-term renal pathologies with characteristics of chronic kidney disease.

AB - Cisplatin is a commonly used chemotherapeutic drug for cancer treatment, but its nephrotoxicity may lead to the deterioration of renal function. Previous work has been focused on cisplatin-induced acute kidney disease, whereas the mechanism of chronic kidney disease after cisplatin chemotherapy is largely unknown. In the present study, we have characterized the mouse model of chronic kidney defects induced by repeated low-dose cisplatin treatment. We have also established a relevant cell culture model. In the animal model, C57 mice were given weekly injection of 8 mg/kg cisplatin for 4 wk. This led to a sustained decline of kidney function. These mice showed loss of kidney mass, interstitial fibrosis, continued activation of inflammatory cytokines, and appearance of atubular glomeruli. In the cell model, the BUMPT mouse proximal tubular cell line was treated four times with 1-2 μM cisplatin, resulting in low levels of apoptosis and the expression of fibrosis proteins and profibrotic factors. These data suggest that repeated treatment with low-dose cisplatin causes long-term renal pathologies with characteristics of chronic kidney disease.

KW - chronic kidney disease

KW - cisplatin

KW - fibrosis

KW - kidney repair

KW - nephrotoxicity

UR - http://www.scopus.com/inward/record.url?scp=85076066150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076066150&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00385.2019

DO - 10.1152/ajprenal.00385.2019

M3 - Article

C2 - 31532246

AN - SCOPUS:85076066150

VL - 317

SP - F1582-F1592

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6

ER -